Literature DB >> 16908160

FXR, a multipurpose nuclear receptor.

Florence Y Lee1, Hans Lee, Melissa L Hubbert, Peter A Edwards, Yanqiao Zhang.   

Abstract

The farnesoid X receptor (FXR) is a ligand-activated transcription factor and a member of the nuclear receptor superfamily. In the past six years, remarkable inroads have been made into determining the functional importance of FXR. This receptor has been shown to have crucial roles in controlling bile acid homeostasis, lipoprotein and glucose metabolism, hepatic regeneration, intestinal bacterial growth and the response to hepatotoxins. Thus, the development of FXR agonists might prove useful for the treatment of diabetes, cholesterol gallstones, and hepatic and intestinal toxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16908160     DOI: 10.1016/j.tibs.2006.08.002

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  110 in total

1.  Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.

Authors:  Zhongsheng Peng; Jiayan Chen; Cinthia B Drachenberg; Jean-Pierre Raufman; Guofeng Xie
Journal:  J Biol Chem       Date:  2019-04-09       Impact factor: 5.157

2.  Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice.

Authors:  Jiyoung Lee; Sunmi Seok; Pengfei Yu; Kyungsu Kim; Zachary Smith; Marcelo Rivas-Astroza; Sheng Zhong; Jongsook Kim Kemper
Journal:  Hepatology       Date:  2012-04-24       Impact factor: 17.425

Review 3.  Adopting new orphans into the family of metabolic regulators.

Authors:  Sarah Hummasti; Peter Tontonoz
Journal:  Mol Endocrinol       Date:  2008-02-07

4.  Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner.

Authors:  Josep Maria Del Bas; Marie-Louise Ricketts; Montserrat Vaqué; Esther Sala; Helena Quesada; Anna Ardevol; M Josepa Salvadó; Mayte Blay; Lluís Arola; David D Moore; Gerard Pujadas; Juan Fernandez-Larrea; Cinta Bladé
Journal:  Mol Nutr Food Res       Date:  2009-07       Impact factor: 5.914

5.  FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.

Authors:  Dong-Ju Shin; Timothy F Osborne
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

6.  Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.

Authors:  Na Wang; Qingan Zou; Jinxin Xu; Jiancun Zhang; Jinsong Liu
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

7.  Poly(ADP-ribose) polymerase 1 promotes oxidative-stress-induced liver cell death via suppressing farnesoid X receptor α.

Authors:  Cheng Wang; Fengxiao Zhang; Lin Wang; Yanqing Zhang; Xiangrao Li; Kun Huang; Meng Du; Fangmei Liu; Shizheng Huang; Youfei Guan; Dan Huang; Kai Huang
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

8.  GATA4 is essential for jejunal function in mice.

Authors:  Michele A Battle; Benjamin J Bondow; Moriah A Iverson; Scott J Adams; Ronald J Jandacek; Patrick Tso; Stephen A Duncan
Journal:  Gastroenterology       Date:  2008-08-03       Impact factor: 22.682

9.  Glucose stimulates cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes.

Authors:  Tiangang Li; Dipanjan Chanda; Yanqiao Zhang; Hueng-Sik Choi; John Y L Chiang
Journal:  J Lipid Res       Date:  2009-10-28       Impact factor: 5.922

10.  Farnesoid X receptor-Acting through bile acids to treat metabolic disorders.

Authors:  Yanqiao Zhang
Journal:  Drugs Future       Date:  2010-08-01       Impact factor: 0.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.